Diabetes and macrovascular disease.

Area of Science:

• Endocrinology
• Cardiology
• Vascular Medicine

Background:

• Cardiovascular disease (CVD) is a leading cause of death in diabetic individuals.
• Macrovascular complications, such as stroke and myocardial infarction (MI), manifest earlier and more severely in diabetes.
• Diabetic arteriopathy involves endothelial dysfunction, hypercoagulability, altered blood flow, and platelet issues, accelerating macrovascular events.

Purpose of the Study:

• To review the impact of diabetes on cardiovascular health.
• To highlight the contribution of diabetic arteriopathy to macrovascular complications.
• To discuss strategies for preventing and managing CVD in diabetic patients.

Main Methods:

• Review of existing literature on diabetes and cardiovascular complications.
• Analysis of the pathophysiology of diabetic arteriopathy.
• Evaluation of therapeutic interventions for CVD risk reduction in diabetes.

Main Results:

• Diabetes significantly increases the risk and severity of macrovascular events.
• Diabetic arteriopathy is a key contributor to premature cardiovascular complications.
• Glycemic control, blood pressure management, and antiplatelet agents show efficacy in secondary prevention.

Conclusions:

• Aggressive management of all cardiovascular risk factors is essential for controlling the epidemic of macrovascular disease in diabetes.
• Optimal glycemic control, blood pressure, LDL levels, and dual antiplatelet therapy (aspirin and clopidogrel) are recommended.
• A multidisciplinary approach addressing all risk factors can contain the rising incidence of macrovascular disease in the diabetic population.